Zakład Badawczo-Wdrożeniowy Ośrodka Salmonella Immunolabsp. z o.o.
Manufacture of pharmaceutical preparations
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2002-03-13
Share capital
50,000.00 PLN
Registered address
ul. Kładki 24, 80-822 Gdańsk, Poland
Electronic delivery address
AE:PL-44159-88809-SFTUB-19
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 60 days late).
- 202526/05/2026
- 202425/06/2025
- 202321/05/2024
- 202203/07/2023
- 202113/09/2022
- 202009/08/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations108 / 231
Top 47%
Results vs industry
Revenue
This companyUSD 1.20mMedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD 182.96kMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 632.12kMedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 1.51mMedianUSD 897.46kAverageUSD 31.52m
Industry
Public procurement
117 tenders recorded as contractor: 112 national ($598,383) and 5 EU ($81,247).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 30, 2026 | Successive supply of reagents and culture media for Powiatowa Stacja Sanitarno-Epidemiologiczna in Płock for 2026 | –– | Powiatowa Stacja-Sanitarno-Epidemiologiczna w Płocku | |
| Oct 21, 2026 | Successive supply and delivery of reagents and reagent kits for microbiological and diagnostic tests | $5,877$5,877 | Wojewódzka Stacja Sanitarno-Epidemiologiczna w Katowicach | |
| Oct 20, 2026 | Purchase and delivery of chemical and laboratory reagents, reference materials, culture media, microbiological tests, diagnostic sera and reference strains for Laboratorium Womp Modlin | –– | 26 Wojskowy Oddział Gospodarczy |
Authorized Representatives
Dorota Ludwika Liederage 59 – President of the Management Board
Krzysztof Głośnickiage 65 – Attorney-in-fact (sole)
Manner of representation
Each member of the management board is authorized to represent the company, make declarations and sign on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 50 | $6,753.11 | 50% | |
Dorota Ludwika Liederage 59 | 50 | $6,753.11 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2001-10-01.
37 1090 1098 0000 0001 4760 9726
Debt
No entries in the National Debtors Register (KRZ).
Public aid
43 public aid cases recorded, with a total value of $7,705,703.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 3, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $258$258 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jul 15, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $384$384 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jul 15, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $352$352 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
5 projects recorded: 4 from FE lists ($8,545,805) and 1 Commission grant (FTS) ($55,318).
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2026-01-01 | ImmunoDiag - Development of an innovative technology for producing tools for broad-based diagnostics | $1.1M$1,123,360 | European Funds for Pomerania 2021-2027 | |
| 2025-03-01 | PhageDi – Development of a modern technology for producing innovative animal-free reagents for the serological identification of Salmonella bacteria. | $2.5M$2,506,089 | European Funds for a Modern Economy | |
| 2020-10-01 | Development of immunological preparations for the prevention and treatment of inflammatory conditions of the udder in cows (mastitis), as alternatives to conventional chemotherapeutics and antibiotics. | $3.6M$3,560,304 | Operational Programme Smart Growth |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zakłady Farmaceutyczne PolpharmaS.A. | $780,704,907.94 | polpharma.pl | ||
| Labofarmsp. z o.o. | $6,814,569.78 | labofarm.pl | ||
| PoltregS.A. | $1,906,011.66 | poltreg.com | ||
| Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Eximsp. z o.o. | $1,592,037.83 | sulphur.com.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Biomarsp. z o.o. | $909,113.28 | biomar.pl | ||
| Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o. | $893,738.50 | lekinatury.pl | ||
| Human BiomeS.A. | $888,361.19 | human-biome.com | ||
| Zeptor Polskasp. z o.o. | $748,374.79 | zeptor.pl | ||
| DR Andresp. z o.o. | $453,987.42 | drandre.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-05-21 | PKD change (Removed: 72.19.Z; Added: 47.61.Z, 58.11.Z, 72.10.Z) | |
| 2019-01-09 | Address change (Al. Zwycięstwa 96/98, 81-451, Gdynia → Ul. Kładki 24, 80-822, Gdańsk) | |
| 2004-02-11 | Address change (Grunwaldzka 230/2, 80-266, Gdańsk → Al. Zwycięstwa 96/98, 81-451, Gdynia) | |
| 2004-02-11 | Share capital increase (20,000.00 PLN → 50,000.00 PLN) | |
| 2002-03-13 | Entered in the register |
FAQ
Last updated: 2026-05-26